Posted by zonked on September 27, 2011, at 23:26:11
In reply to :-) » Everyone, posted by SLS on September 27, 2011, at 21:37:46
There are advocacy group for most conditions, but none that I am aware of for treatment-resistant depression (unipolar or bipolar.)
Depression robs one of energy, so perhaps that's a reason.
I don't think we are so few in number so as to not warrant an advocacy group of our own. No, NAMI doesn't count.
It's something I've been thinking about off and on. Unfortunately, of the many things I do graphic design and website design aren't among them.
I wonder if having such a group would get any attention (press perhaps?) or pressure pharma to consider us a distinct group to study in trials.
As far as I know, the only drugs with FDA *indications* for TRD are Symbyax (Zyprexa with Prozac) and Marplan.
Just an idea. Maybe if I return to full functioning (including occupational) this is a cause I could devote some time to.
I think if big pharma pursued indications for TRD as well as MDD for novel compound they might sell more product. Having said that, the product would have to be effective for TRD. TRD-ers are often excluded from trials for various reasons (previous suicide attempts, I believe, being one of them.)
What do you guys think?